01 / DESIGN
What was studied?
An oral-supplementation study followed diabetic participants receiving background treatment and measured redox and glycemic biomarkers over six months.
02 / FINDINGS
What did the researchers report?
Blood glutathione increased and selected oxidative-damage markers decreased. Some glycemic findings were reported in a post hoc older subgroup rather than uniformly across participants.
03 / LIMITS
How should it be interpreted?
Subgroup findings require confirmation and should not replace the overall result. Biomarker changes do not establish prevention of diabetes complications or justify treatment substitution.
Voltera Peptide editorial reading note. Based on the linked source record. Methods and corrections.